|
Summary:
Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V For Medicinal Products With The Active Ingredient Budesonide (Except Inhalativa And At Least With A Admission To The Indication Of Chronic Inflammatory Bowel Disease) (Atc Code: A07Ea . Country:
Germany
Notice Type:
Tender Notice Deadline:
27 Aug 2027 Posting Date:
10 Sep 2025 |
|
Summary:
Open Framework Agreement On Pharmaceutical Discounts In Accordance With Section 130A (8) Sgb V With Any Time, So-Called Registration Model 2025-09 Country:
Germany
Notice Type:
Tender Notice Deadline:
05 Sep 2027 Posting Date:
10 Sep 2025 |
|
Summary:
Open Framework Agreement On Pharmaceutical Discounts In Accordance With Section 130A (8) Sgb V With Any Time, So-Called Registration Model 2025-09 Country:
Germany
Notice Type:
Tender Notice Deadline:
05 Sep 2027 Posting Date:
10 Sep 2025 |
|
Summary:
Open House Biologika Discount Contracts 2025-26-Insulin Lispro (Atc: A10Ab04, Effectiveness: 100 U/Ml) Country:
Germany
Notice Type:
Tender Notice Deadline:
31 Oct 2027 Posting Date:
10 Sep 2025 |
|
Summary:
Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V On Pharmaceuticals With The Active Ingredient Tencilizumab (Atc Code: L04Ac07). Country:
Germany
Notice Type:
Tender Notice Deadline:
27 Aug 2027 Posting Date:
09 Sep 2025 |
|
Summary:
Delivery Of Edta Plasma Country:
Germany
Notice Type:
Tender Notice Deadline:
28 Sep 2025 Posting Date:
09 Sep 2025 |
|
Summary:
Test Pp 09.9.25 Country:
Germany
Notice Type:
Prior Information Deadline:
09 Sep 2026 Posting Date:
09 Sep 2025 |
|
Summary:
Open House Original Discount Contracts 2025-26 - Ponesimod Country:
Germany
Notice Type:
Tender Notice Deadline:
31 Oct 2027 Posting Date:
09 Sep 2025 |
|
Summary:
Medicines And Medical Devices Subject To Pharmacy Country:
Germany
Notice Type:
Tender Notice Deadline:
15 Oct 2025 Posting Date:
09 Sep 2025 |
|
Summary:
Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V On Pharmaceuticals With The Active Ingredient Tencilizumab (Atc Code: L04Ac07). Country:
Germany
Notice Type:
Tender Notice Deadline:
27 Aug 2027 Posting Date:
09 Sep 2025 |
Most trusted source for Tendering Opportunities and Business Intelligence since 2002